Fighting cancer with everything we know™
We believe that knowledge is power. And in the fight versus cancer, AccessHope deploys the latest evidence-based recommendations, research, knowledge, and insights to employees and their treating oncologists across the country, regardless of their zip code.
A troubling gap exists between cancer treatment and cancer outcomes. The contributing factors to cancer are complex, such as genetics, differences in access to quality care, and a lack of medical research across diverse study subjects.
Read more
Cancer is a leading cause of mortality in the United States and across the world. It also is one of the major illnesses that cause individuals to worry. Cancer can be diagnosed through screening, when it is asymptomatic, or when symptoms are present.
Read more
Cancer research and treatments are developing at an extraordinary pace, leading to a knowledge gap between large academic institutions and community practices.
Read more
AccessHope achieves HITRUST CSF® Certification. This achievement places AccessHope in an elite group of organizations worldwide that have earned this certification and enables us to serve our customers and people with cancer with the highest standard of security and privacy.
Read more
With almost 2 million new cancer diagnoses every year,1 nearly every person in the United States has been touched by the disease – either personally or through a loved one, friend, or colleague. Fortunately, cancer knowledge is growing rapidly, and researchers are making continuous strides in developing new treatments and advancing diagnostics.
Read more
Breast Cancer Awareness Month is an opportune time to highlight the importance of understanding breast cancer’s impact, undergoing breast screening tests, and conducting breast self-exams.
Read more
Nitya Nathwani, M.D., joined AccessHope as a part of its Expert Oncology Team. Dr. Nathwani’s clinical and research interests center on multiple myeloma. He has been the principal investigator at City of Hope for 2 landmark clinical trials in multiple myeloma, including quadruplet induction therapy that has changed the myeloma treatment landscape, and a trial defining the role of transplant in the US.
Read more
Studies show that academic oncologists are using biomarker testing at a higher percentage than community-based oncologists, despite national guidelines. Learn why, and how cancer experts well-versed in the latest testing and treatments can help close this knowledge gap in cancer care.
Read more
In today's market, employers need to provide more than competitive wages to attract and retain top talent. Employers need to offer benefits that support employees' health and well-being to maintain an engaged and productive workforce.
Read more
People with cancer experience a range of emotions upon receiving their diagnosis. By offering AccessHope’s cancer-focused employee benefit, employers can connect them to the supportive services they need for their mental health.
Read more